Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shona Fang

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Scientific Reports|July 11, 2025
Incidence and prevalence of light chain amyloidosis in the United States in 2019-2021 using Optum EHR dataPedro A Laires, Shona Fang, Jennifer Evans, et al.
Psychosomatic Medicine|September 28, 2011
Optimism in relation to inflammation and endothelial dysfunction in older men: the VA Normative Aging StudyAi Ikeda, Joel Schwartz, Junenette L Peters, et al.
Bone|June 28, 2026
Burden of disease in US patients with skeletal versus muscular or pain manifestations of hypophosphatasia: An analysis from the Global HPP RegistryPriya S Kishnani, Steven Ing, Julie Hoover-Fong, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 13, 2020
Burden of Illness in Adults With Hypophosphatasia: Data From the Global Hypophosphatasia Patient RegistryLothar Seefried, Kathryn Dahir, Anna Petryk, et al.
Endocrine Connections|March 14, 2023
Growth and disease burden in children with hypophosphatasiaWolfgang Högler, Agnès Linglart, Anna Petryk, et al.
BMC Musculoskeletal Disorders|February 16, 2019
Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registryWolfgang Högler, Craig Langman, Hugo Gomes da Silva, et al.
Hormone Research in Paediatrics|July 13, 2023
Clinical Profiles of Children with Hypophosphatasia prior to Treatment with Enzyme Replacement Therapy: An Observational Analysis from the Global HPP RegistryGabriel Ángel Martos-Moreno, Cheryl Rockman-Greenberg, Keiichi Ozono, et al.
Orphanet Journal of Rare Diseases|July 19, 2022
Clinical profiles of treated and untreated adults with hypophosphatasia in the Global HPP RegistryKathryn M Dahir, Lothar Seefried, Priya S Kishnani, et al.
Advances in Therapy|March 26, 2025
Mobility and Quality of Life in Adults with Paediatric-Onset Hypophosphatasia Treated with Asfotase Alfa: Results from UK Managed Access AgreementKatie E Moss, Richard Keen, Shona Fang, et al.
Orphanet Journal of Rare Diseases|March 8, 2024
Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registryPriya S Kishnani, Gabriel Ángel Martos-Moreno, Agnès Linglart, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Scientific Reports|July 11, 2025
Incidence and prevalence of light chain amyloidosis in the United States in 2019-2021 using Optum EHR dataPedro A Laires, Shona Fang, Jennifer Evans, et al.
Psychosomatic Medicine|September 28, 2011
Optimism in relation to inflammation and endothelial dysfunction in older men: the VA Normative Aging StudyAi Ikeda, Joel Schwartz, Junenette L Peters, et al.
Bone|June 28, 2026
Burden of disease in US patients with skeletal versus muscular or pain manifestations of hypophosphatasia: An analysis from the Global HPP RegistryPriya S Kishnani, Steven Ing, Julie Hoover-Fong, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 13, 2020
Burden of Illness in Adults With Hypophosphatasia: Data From the Global Hypophosphatasia Patient RegistryLothar Seefried, Kathryn Dahir, Anna Petryk, et al.
Endocrine Connections|March 14, 2023
Growth and disease burden in children with hypophosphatasiaWolfgang Högler, Agnès Linglart, Anna Petryk, et al.
BMC Musculoskeletal Disorders|February 16, 2019
Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registryWolfgang Högler, Craig Langman, Hugo Gomes da Silva, et al.
Hormone Research in Paediatrics|July 13, 2023
Clinical Profiles of Children with Hypophosphatasia prior to Treatment with Enzyme Replacement Therapy: An Observational Analysis from the Global HPP RegistryGabriel Ángel Martos-Moreno, Cheryl Rockman-Greenberg, Keiichi Ozono, et al.
Orphanet Journal of Rare Diseases|July 19, 2022
Clinical profiles of treated and untreated adults with hypophosphatasia in the Global HPP RegistryKathryn M Dahir, Lothar Seefried, Priya S Kishnani, et al.
Advances in Therapy|March 26, 2025
Mobility and Quality of Life in Adults with Paediatric-Onset Hypophosphatasia Treated with Asfotase Alfa: Results from UK Managed Access AgreementKatie E Moss, Richard Keen, Shona Fang, et al.
Orphanet Journal of Rare Diseases|March 8, 2024
Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registryPriya S Kishnani, Gabriel Ángel Martos-Moreno, Agnès Linglart, et al.
Pageof 3